Pricing Log in Create free account

Context Therapeutics Inc. (CNTX) vs Estrella Immunopharma, Inc. (ESLA)

Context Therapeutics Inc. and Estrella Immunopharma, Inc. are both Biotechnology companies. Context Therapeutics Inc. and Estrella Immunopharma, Inc. are of similar size ($17.8M and $17.3M). Across the 7 metrics below, Estrella Immunopharma, Inc. leads on 4 and Context Therapeutics Inc. on 3.

Valuation

Metric CNTX ESLA Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 0.47 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.51 n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield (252.63%) (65.92%) (32.88%)
Free cash flow yield (188.15%) (58.98%) (23.13%)

Profitability

Metric CNTX ESLA Biotechnology median
Gross margin 0.00% — 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (76.14%) 148.05% (51.96%)
Return on assets (68.96%) (416.74%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CNTX ESLA Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 17.39% (188.78%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CNTX ESLA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.81 0.20 4.97
Net debt to EBITDA 1.66 0.11 1.01

Dividend

Metric CNTX ESLA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CNTX ESLA Biotechnology median
Market cap 17.27m 17.84m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack